Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 869 record(s)

Req # A-2019-001256

Adverse Drug Reactions (ADRs). Report numbers: 724669, 724687, E2B_01448668, E2B_02434051, E2B_02563995, E2B_02577326, E2B_02602335, E2B_02330475, E2B_00774315, E2B_00495172, 000421455, 000667254, E2B_01303522, E2B_01100355, E2B_01049165, E2B_00559611, E2B_00481009, E2B_00474441, E2B_00501709, E2B_01130834, E2B_01238020, E2B_00503050, E2B_00790927, E2B_01429588, 000702024, E2B_01436737, E2B_01431266, E2B_01499886, 000697440, E2B_01441806, E2B_01479209, E2B_01491941, E2B_0250996 E2B_02630186, E2B_02461794.

Organization: Health Canada

1891 page(s)
March 2023

Req # A-2019-001917

Adverse Drug Reaction (ADR). Report number: E2B_02737965.

Organization: Health Canada

63 page(s)
March 2023

Req # A-2020-001071

Adverse Drug Reactions (ADRs). Report numbers: 000733113, 000733771, 000733785, 000734258, 000734805, 000735056, 000735314, 000735438, 000735633, 000735649, 000735685, 000735860, 000736269, 000736408, 000736423, 000736424, 000736448, 000736542, 000736550, 000736566.

Organization: Health Canada

44 page(s)
March 2023

Req # A-2020-001142

Adverse Drug Reactions (ADRs). Report numbers: E2B_02408678, 000723556, 000723571, 000723605, 000725632, E2B_02749590, E2B_02754910, E2B_02775229, E2B_02775080, 000731357.

Organization: Health Canada

99 page(s)
March 2023

Req # A-2020-001376

Adverse Drug Reactions (ADRs). Report numbers: E2B_02824132, E2B_02824302, E2B_02824749, E2B_02824813, E2B_02825174, E2B_02825965, E2B_02826468, E2B_02827025, E2B_02828986, E2B_02829485, E2B_02829823, E2B_02830941, E2B_02831180, E2B_02831849, E2B_02831935, E2B_02833072, E2B_02833805, E2B_02833832, E2B_02833895, E2B_02834177.

Organization: Health Canada

379 page(s)
March 2023

Req # A-2020-001520

Adverse Drug Reactions (ADRs). Report numbers: E2B_02838453, E2B_02898095, E2B_02888853, E2B_02867108, E2B_02871955, E2B_02889192, E2B_02900104, E2B_02919692, E2B_02901950, E2B_02904781, E2B_02910250, E2B_02908442, 000734809, E2B_02920063, E2B_02957403, E2B_02968298, E2B_02922429, E2B_02926666, E2B_02926851, E2B_02927389.

Organization: Health Canada

280 page(s)
March 2023

Req # A-2020-001806

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115888-559.

Organization: Health Canada

26 page(s)
March 2023

Req # A-2020-001866

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115888-559.

Organization: Health Canada

28 page(s)
March 2023

Req # A-2021-000128

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115888-559.

Organization: Health Canada

28 page(s)
March 2023

Req # A-2021-000990

Adverse Drug Reaction (ADR) for DANAZO. Report number: E2B_03588005.

Organization: Health Canada

8 page(s)
March 2023
Date modified: